Weekly shot could replace daily growth hormone injections for kids
NCT ID NCT05690386
Summary
This study is testing a new, long-acting growth hormone called lonapegsomatropin that is given as a single injection once a week. It is being compared to the standard daily growth hormone injections in prepubertal children with Turner syndrome to see if it is safe and works just as well to help them grow taller. The goal is to find the best dose and see if a weekly option can provide the same benefits with fewer injections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TURNER SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ascendis Pharma Investigational Site
Palo Alto, California, 94304, United States
-
Ascendis Pharma Investigational Site
San Diego, California, 92123, United States
-
Ascendis Pharma Investigational Site
Aurora, Colorado, 80045, United States
-
Ascendis Pharma Investigational Site
Orlando, Florida, 32827, United States
-
Ascendis Pharma Investigational Site
St. Petersburg, Florida, 33701-4804, United States
-
Ascendis Pharma Investigational Site
Atlanta, Georgia, 30322, United States
-
Ascendis Pharma Investigational Site
Idaho Falls, Idaho, 83404, United States
-
Ascendis Pharma Investigational Site
Chicago, Illinois, 60611, United States
-
Ascendis Pharma Investigational Site
Boston, Massachusetts, 02114, United States
-
Ascendis Pharma Investigational Site
Saint Paul, Minnesota, 55102, United States
-
Ascendis Pharma Investigational Site
Las Vegas, Nevada, 89113, United States
-
Ascendis Pharma Investigational Site
Lake Success, New York, 11042, United States
-
Ascendis Pharma Investigational Site
Chapel Hill, North Carolina, 27599, United States
-
Ascendis Pharma Investigational Site
Cincinnati, Ohio, 45229, United States
-
Ascendis Pharma Investigational Site
Oklahoma City, Oklahoma, 73104, United States
-
Ascendis Pharma Investigational Site
Portland, Oregon, 97239, United States
-
Ascendis Pharma Investigational Site
El Paso, Texas, 79902, United States
-
Ascendis Pharma Investigational Site
Fort Worth, Texas, 76104, United States
-
Ascendis Pharma Investigational Site
Seattle, Washington, 98105, United States
Conditions
Explore the condition pages connected to this study.